The Surgery/Trauma Clinical Research Unit (CRU) is a dedicated unit within the Department of Surgery, actively engaged in conducting and documenting state-of-the-art, industry-sponsored clinical trials, safely and ethically, in full compliance with federal regulations, good clinical practice, institutional, Institutional Review Board and sponsor requirements.

 

As the name implies, the Surgery/Trauma CRU specializes in conducting studies involving the prevention and management of the consequences of trauma, in all its phases and environments, including: transportation from the scene of injury, the Emergency Department, the Operating Room, the Post-Anesthesia Care Unit and Surgical Intensive Care Unit, as well as subsequent inpatient and outpatient hospital care. 

 

In this setting, indications for prophylactic or therapeutic intervention with investigational products (whether pharmaceutical, biologic or device) include but are not limited to: hemorrhagic shock, septic shock, hypothermia, anemia, hemostasis, ischemia, analgesia, inflammation, infection, healing (bone/wound), clotting disorders, post-operative bowel dysfunction, and organ failure.

 

Patients undergoing and/or recovering from emergent and elective surgery are routinely considered for inclusion in relevant clinical trials.

 

All trials are conducted under the supervision of Ernest E. Moore M.D., Chief of Surgery and Trauma Services.  Close cooperation between the Paramedic Division, Emergency Medicine, Anesthesiology and Surgery Departments ensures successful research collaboration.

 

Contact Information:

 

Elizabeth M. Ryder, B.Pharm, D.H.P.

   Director, Surgery/Trauma CRU

 

Ernest E. Moore, MD

   Chief of Surgery and Trauma Services